ALPHAPORT.AI
🇺🇸SOBR Safe, Inc.SOBR
USDUSD
SectorInformation TechnologyIndustryPrecision Instruments
Management
David J. Gandini
CEO

Company information

Ticker
SOBR
Country
United States
Sector
Information Technology
Industry
Precision Instruments

SOBR Safe Business Summary

SOBR Safe, Inc. (NASDAQ: SOBR) operates a technology-driven safety model centered on non-invasive, transdermal alcohol detection. The company generates revenue through a dual-stream approach: hardware sales of its proprietary devices and recurring monthly SaaS subscription fees for its cloud-based data platform. Its primary business segments include stationary access control (SOBRcheck), designed for centralized workplace screening in logistics and manufacturing, and wearable continuous monitoring (SOBRsure), a fitness-style wristband targeting fleet management, teen drivers, and the behavioral health market. Positioned as a hygienic, preventative alternative to traditional breathalyzers, SOBR Safe competes directly with established alcohol monitoring firms such as SCRAM Systems, Smart Start, and Lifeloc Technologies, distinguishing itself through passive, touch-based sensing that eliminates the need for breath, blood, or urine samples. Originally founded in 2004 as TransBiotec, Inc., the company is currently led by Chairman and CEO David J. Gandini, a serial entrepreneur with a deep pedigree in telecommunications and technology, having previously served as COO of First World Communications and President of IPS Denver. The executive team includes CFO Christopher Whitaker, a CPA with over 30 years of experience at firms like KPMG and Elixinol, and CTO Dean Watson, who brings an extensive background in automotive technology and intellectual property management with over 1,600 patents to his credit. The board of directors features high-profile members including Steve Beabout, former General Counsel of Starz, and Kris Pederson, a retired partner from EY and PwC. Recent institutional backing includes a $2 million private placement closed in late 2025, reflecting continued investor confidence in the company’s transdermal detection roadmap.

Updated 2026-07-31 · US SEC company filings
Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.